The SSO Clinical Project Manager (CPM) is accountable for the day-to-day planning, executing and
reporting, (from first site initiation visit to and including study site close-out), of assigned Global Drug
Development (GDD) studies in compliance with Novartis processes and regulatory requirements.
The CPM is the single point of contact and study team lead, within the country/cluster/hub, for the
assigned studies. The CPM is responsible for assuring aligned communication with Trial Lead and
other CTT members, locally with Clinical Research Associates (CRAs), CRA Managers and other key
associates on the execution and progress of their studies. The CPM collaborates with the SSO Country
Manager, SSO Country Head, SSO Feasibility Manager, SSO Study Start-up Manager and SSO Site
Partnership Manager in the planning, execution, and delivery of their assigned studies. Accountable
for execution and reporting of assigned GDD studies in E2E product line Clinical Operations Program
Head/Study Lead/ CPM – CRA. Can be assigned partially to participate in the review process of Site
Monitoring Plans across Portfolio.
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-culture
Benefits and Rewards: Learn about all the ways we’ll help you thrive personally and professionally.
Read our handbook (PDF 30 MB)
